home / stock / govxw / govxw quote
Last: | $0.0345 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0345 |
High: | $0 |
Low: | $0 |
Volume: | 30 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0345 | $0 | $0.0345 | $0 | $0 | 30 | 04-29-2024 |
$0.0345 | $0 | $0.0345 | $0 | $0 | 95 | 04-22-2024 |
$0.0345 | $0.0345 | $0.0345 | $0.0345 | $0.0345 | 1,222 | 04-19-2024 |
$0.0491 | $0 | $0.0491 | $0 | $0 | 100 | 04-18-2024 |
$0.0491 | $0.049 | $0.0491 | $0.0491 | $0.049 | 300 | 04-17-2024 |
$0.0499 | $0.0499 | $0.0499 | $0.0499 | $0.0499 | 6,000 | 04-15-2024 |
$0.05 | $0.0399 | $0.05 | $0.05 | $0.0399 | 4,000 | 04-11-2024 |
$0.0288 | $0.0288 | $0.0288 | $0.0288 | $0.0288 | 1,000 | 04-08-2024 |
$0.036986 | $0.033299 | $0.036986 | $0.04 | $0.033299 | 3,500 | 04-04-2024 |
$0.026701 | $0.026701 | $0.026701 | $0.026701 | $0.026701 | 201 | 04-03-2024 |
$0.0268 | $0.0266 | $0.0268 | $0.04 | $0.0266 | 1,868 | 04-02-2024 |
$0.0266 | $0.02661 | $0.02661 | $0.0266 | $0.0266 | 100 | 03-29-2024 |
$0.02661 | $0.02661 | $0.02661 | $0.02661 | $0.02661 | 100 | 03-28-2024 |
$0.0266 | $0.0266 | $0.0266 | $0.0266 | $0.0266 | 375 | 03-27-2024 |
$0.0401 | $0 | $0.0401 | $0 | $0 | 190 | 03-26-2024 |
$0.0401 | $0.0448 | $0.0401 | $0.0448 | $0.04 | 400 | 03-21-2024 |
$0.0316 | $0.035701 | $0.0316 | $0.035701 | $0.0316 | 700 | 03-13-2024 |
$0.0255 | $0 | $0.0255 | $0 | $0 | 5 | 03-07-2024 |
$0.0255 | $0.0298 | $0.0255 | $0.045 | $0.0255 | 3,382 | 03-06-2024 |
$0.026203 | $0.02755 | $0.026203 | $0.02755 | $0.0251 | 7,400 | 03-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
GeoVax Labs Inc. Warrants Company Name:
GOVXW Stock Symbol:
NASDAQ Market:
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs...
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced ...
ATLANTA, GA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD, will presen...